Competitive intelligence on
small-molecule drugs and
the 90,000 global patents
|Title:||Powders for inhalation|
|Abstract:||In order to control and optimize the amount of inhalable active substance released when drugs are administered as inhalation powders, the invention calls for the use of auxiliaries consisting of mixtures of coarser particles (average particle size>20 .mu.m) and finer particles (average particle size<10 .mu.m).|
|Inventor(s):||Arnold; Klaus (Ingelheim am Rhein, DE), Grass; Peter (Ingelheim am Rhein, DE), Knecht; Adolf (Freiburg, DE), Roos; Robert (Ingelheim am Rhein, DE), Sluke; Gerhard (Ingelheim am Rhein, DE), Thieme; Herbet (Ingelheim am Rhein, DE), Wenzel; Joachim (Ingelheim am Rhein, DE)|
|Assignee:||Boehringer Ingelheim KG (Ingelheim am Rhein, DE)|
Patent Claim Types:|
see list of patent claims
|Country||Document Number||Publication Date|
|Japan||3567329||Sep 22, 2004|
|Japan||H08501056||Feb 06, 1996|
|Greece||3026516||Jul 31, 1998|
|World Intellectual Property Organization (WIPO)||9311746||Jun 24, 1993|
|Australia||670555||Jul 25, 1996|
|This preview shows a limited data set|
Subscribe for full access, or try a free trial
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.